Dr. Alaa Nabil Ahmed Elmazny
Dr. Alaa Nabil Ahmed Elmazny
Bio
Academic Background
Research Interests
Selected Publications
Bio
Dr. Alaa Elmazny graduated with distinction, earning her MBBCh degree in Medicine and Surgery from Cairo University. Continuing her academic pursuits, she went on to achieve a Master’s degree in Neuropsychiatry in 2011 and a Ph.D. in Neurology in 2015. Dr. Elmazny’s expertise has been acknowledged with the prestigious Fellowship of the European Board of Neurology, awarded to her in 2022. She served as a principal investigator in research projects focused on multiple sclerosis, headache and epilepsy and has also served as a peer reviewer for various indexed journals including the multiple sclerosis and related disorders and therapeutic advances in neurological disorders journals. Currently, Dr. Elmazny serves as a consultant neurologist at King Abdullah Medical City in Bahrain, holds the position of an assistant professor of internal medicine at the Arabian Gulf University, and is also an associate professor of neurology at Cairo University, Egypt.
Academic Background
• European board of neurology , 2022
• Doctorate degree in neurology – Faculty of medicine – Cairo University – Egypt ,2015
• Master’s degree in Neurology and psychiatry -Faculty of Medicine-Cairo University – Egypt , 2011
• Bachelor of Medicine and Surgery – Faculty of Medicine – Cairo University – Egypt (with honors) , 2006
Research Interests
• Multiple sclerosis
• Headache
• Epilepsy
Selected Publications
1. Public misconceptions and attitudes towards persons diagnosed with epilepsy in the Kingdom of Bahrain: A cross-sectional study. Epilepsy & Behavior journal 153 (2024): 109731. Elmazny, A, Mohammed Ahmed A. Alkharisi, Yazed Saad J. Ibrahim, Atheer Baalqasim A. Albarakati, Shatha Shayan Almutairi, Lina Abdulrahim Altalhi, Enas Mostafa Darwish, Rehab Magdy, Eman Hany Elsebaie, and Ahmed Dahshan.
2. Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. European Archives of Psychiatry and Clinical Neuroscience journal. 2023 Sep;273(6):1349-1358. Elmazny A, Magdy R, Hussein M, Elsebaie EH, Ali SH, Abdel Fattah AM, Hassan M, Yassin A, Mahfouz NA, Elsayed RM, Fathy W, Abdel-Hamid HM, Abdelbadie M, Soliman SH.
3. Knowledge, awareness, and attitudes towards epilepsy among elementary schoolteachers in the Kingdom of Bahrain. European journal of pediatric neurology. 2023 Nov;47:13. Elmazny A, Alzayani S, Shehata MH, Magdy R.
4. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study The journal of headache and pain 2022 Aug 12;23(1):101 Magdy R, Elmazny A, Soliman SH, Elsebaie EH, Ali SH, Abdel Fattah AM, Hassan M, Yassien A, Mahfouz NA, Elsayed RM, Fathy W, Abdel-Hamid HM, Mohamed J, Hussein M.
5. Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization. Journal of pain research 2020 Mar 11;13:537-545. Elmazny A, Hamdy SM, Abdel-Naseer M, Shalaby NM, Shehata HS, Kishk NA, Nada MA, Mourad HS, Hegazy MI, Abdelalim A, Ahmed SM, Hatem G, Fouad AM, Mahmoud H, Hassan A